Fomesafen, a long residual diphenyl ether herbicide, is widely used for control of annual and perennial broadleaf weeds in peanut and soybean fields. With the development of agricultural production mechanization in China, the application of fomesafen has been rising. Long-term and large-scale application leads to obvious residues in the soil. As a consequence, the resulting ecological and environmental problems need urgent attention from the agricultural and environmental protection departments. We systematically reviewed the research progress about the residual characteristics, ecotoxicological effects and abatement process of fomesafen in farmland soil, and proposed some prospects from the residual formation mechanisms, safe application limit standard, abatement mechanism and technology, aiming to provide some new insights and ideas for solving the problem of residual injury of fomesafen.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.13287/j.1001-9332.202303.032 | DOI Listing |
Polymers (Basel)
January 2025
Department of Mechanical and Aerospace Engineering, Politecnico di Torino, 10129 Turin, Italy.
This paper experimentally investigates the impact response of composite laminates made with conventional and bio-based epoxy resin. Drop tower impact tests were conducted at varying energy levels, including repeated low-energy impacts, to evaluate perforation resistance. The laminates' residual strength and damage tolerance were assessed using the Damage Index (DI) and by analysing the resonance frequency variations through the Impulse Excitation Technique (IET).
View Article and Find Full Text PDFJ Clin Med
January 2025
Eye Clinic, ASST Santi Paolo e Carlo Hospital, University of Milan, 20142 Milan, Italy.
Retinitis pigmentosa (RP) is a heterogeneous group of inherited retinal diseases characterized by the progressive loss of photoreceptor function, visual impairment, and, ultimately, blindness. While gene therapy has emerged as a promising therapy, it is currently available only for the RPE65 gene mutation, leaving many patients without targeted genetic treatments. Non-surgical interventions may help in managing the progression of RP and improving patients' quality of life.
View Article and Find Full Text PDFMedicina (Kaunas)
January 2025
Department of Biomedical Sciences, Dubai Medical College for Girls, Dubai 20170, United Arab Emirates.
Eclampsia is a multisystem disorder of pregnancy and the puerperium. Posterior reversible encephalopathy syndrome (PRES), a neurotoxic condition characterized by various neurological symptoms, can arise from multiple causes including eclampsia. Although hemorrhage is a possible complication of PRES, subarachnoid hemorrhage (SAH) is a rare occurrence in eclamptic patients with this condition.
View Article and Find Full Text PDFMedicina (Kaunas)
December 2024
Department of Ultrasound, Peking University Third Hospital, Beijing 100191, China.
In this study, we assessed the utility of ultrasonography in monitoring the chemotherapeutic effects on primary thyroid lymphoma (PTL). This retrospective analysis included 17 patients with PTL who received chemotherapy from 2012 to 2022. The sonographic features were examined pre- and post-treatment using ultrasound (US) to monitor the treatment response at the first to second, third to fourth, and end cycles of chemotherapy and follow-up, and progression-free survival (PFS) and overall survival (OS) were analyzed.
View Article and Find Full Text PDFCancers (Basel)
January 2025
Canarian Insitute for Cancer Research, 380204 San Cristobal de La Laguna, Spain.
Objective: We demonstrated for the first time the safety and feasibility of escalating up to 55 Gy/11 Gy/fr/5fr in borderline (BRPC)/unresectable locally advanced pancreatic cancer (LAPC), using the standard LINAC platform. The aim of the present study is to assess for the first time the impact of this high-dose neoadjuvant stereotactic ablative radiotherapy (SABRT) protocol on tumor resectability and pathological responses.
Materials/methods: From June 2017 to December 2022, patients with BRPC/LAPC were treated with neoadjuvant chemotherapy (ChT) and SABRT-escalated doses of SIB at 45 Gy, 50 Gy, and up to 55 Gy (BED ≥ 100).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!